TLR4 and epilepsy: Overexpression of miR-636 inhibiting IL1R1 expression could markedly downregulate the TLR4 signalling pathway not just in CF but also in other diseases, such as epilepsy, in which inactivation of the IL1R1/TLR4 pathway is implicated (45).